IDEX Corp
F:ID7
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
IDEX Corp
F:ID7
|
US |
|
H
|
HP Inc
F:7HP
|
US |
|
Kikkoman Corp
OTC:KIKOF
|
JP |
|
Integra Lifesciences Holdings Corp
NASDAQ:IART
|
US |
|
C
|
Cardiff Oncology Inc
SWB:XE7C
|
US |
|
Zotefoams PLC
F:23Z
|
UK |
|
Swan Defence and Heavy Industries Ltd
NSE:SWANDEF
|
IN |
|
Burcon NutraScience Corp
TSX:BU
|
CA |
IDEX Corp
IDEX Corp makes specialized industrial equipment used to move, control, measure, and dispense fluids and other materials. Its products include pumps, valves, flow meters, and fire and rescue tools, along with precision parts used in laboratory and medical systems. The company sells to industrial customers, equipment makers, water and wastewater users, life sciences companies, and emergency response teams. IDEX makes money mainly by selling this equipment and by supplying replacement parts and service over time. A lot of its business comes from mission-critical products that customers need to keep factories, labs, and public safety systems running. That gives it a mix of upfront equipment sales and recurring aftermarket demand. What makes IDEX different is that it focuses on narrow, high-value niches rather than mass-market products. Its role is often one step behind the end user and one step ahead of the final system builder: it supplies the specialized components that make larger machines and systems work reliably. That makes its business tied to essential industrial, scientific, and safety applications rather than consumer demand.
IDEX Corp makes specialized industrial equipment used to move, control, measure, and dispense fluids and other materials. Its products include pumps, valves, flow meters, and fire and rescue tools, along with precision parts used in laboratory and medical systems. The company sells to industrial customers, equipment makers, water and wastewater users, life sciences companies, and emergency response teams.
IDEX makes money mainly by selling this equipment and by supplying replacement parts and service over time. A lot of its business comes from mission-critical products that customers need to keep factories, labs, and public safety systems running. That gives it a mix of upfront equipment sales and recurring aftermarket demand.
What makes IDEX different is that it focuses on narrow, high-value niches rather than mass-market products. Its role is often one step behind the end user and one step ahead of the final system builder: it supplies the specialized components that make larger machines and systems work reliably. That makes its business tied to essential industrial, scientific, and safety applications rather than consumer demand.
Strong quarter: IDEX beat expectations in Q1 with 5% organic sales growth, 10% organic order growth, and adjusted EBITDA margin of 26%, helped by strong performance in Health & Science Technologies.
Guidance raised: Full-year 2026 organic growth guidance was increased to 3% to 4% from 1% to 2%, and adjusted EPS guidance was raised by $0.20 to $8.35 to $8.55.
HST led the call: Health & Science Technologies saw 17% organic order growth and 11% organic sales growth, with management pointing to data center, semiconductor, space and defense, and pharma strength.
Mixed industrial backdrop: Fluid & Metering Technologies and Fire & Safety / Diversified Products showed signs of improvement, but management stayed cautious because of macro and geopolitical uncertainty.
Capital returns continue: IDEX repurchased $76 million of stock in Q1 and expects to keep that pace through 2026, while still funding growth CapEx and bolt-on M&A.
Tariffs manageable: Management said the new tariffs are largely consistent with the repealed ones and do not expect much net impact to results at this point.
